ImmunityBio Logo

ImmunityBio

🇺🇸
IBRX
US45256X1037

ImmunityBio is a U.S.-based biotechnology company specializing in the development of innovative immunotherapies to combat cancer and infectious diseases. By leveraging advanced cell therapies and vaccine platforms, ImmunityBio aims to strengthen the body’s natural immune system to target these diseases.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will ImmunityBio report its next quarterly earnings?

ImmunityBio is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did ImmunityBio last report quarterly earnings?

ImmunityBio last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.22 USD.

How does ImmunityBio stock react to earnings?

Across its last 3 earnings reports, ImmunityBio stock moved by ±7.7% on average the following day. The largest reaction was +13% on 02/23/2026; 1 of 3 reactions were positive.

How often has ImmunityBio beaten expectations?

ImmunityBio has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the ImmunityBio earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.08
Actual:
Q2 2026
Missed
Estimate:-$0.08
Actual:-$0.22
Difference:-$0.14
Price reaction (1 day):-2.8 %
Price reaction (7 days):+6.3 %
Q1 2026
Missed
Estimate:-$0.07
Actual:-$0.62
Difference:-$0.55
Price reaction (1 day):-7.4 %
Price reaction (7 days):-2.7 %
Q4 2025
Beat
Estimate:-$0.08
Actual:-$0.06
Difference:+$0.02
Price reaction (1 day):+13.0 %
Price reaction (7 days):+20.0 %
Q2 2025
Beat
Estimate:-$0.10
Actual:-$0.07
Difference:+$0.03
Q1 2025
Met
Estimate:-$0.10
Actual:-$0.10
Difference:+$0.00

Earnings statistics

Stock reaction to earnings

±7.7%
Avg. next-day move
+13%
Largest move (02/23/2026)
33.3%
Share of positive reactions
±9.7%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-186.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
ImmunityBio
Ticker Symbol
IBRX
ISIN
US45256X1037
Country
🇺🇸
USA
Sector
More Financial Information